Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
11/29/2007
Trade Name:
Diovan
Generic or Proper Name (*):
valsartan
Indications Studied:
Hypertension
Therapeutic Category:
Antihypertensive
Ages Studied:
1-16 years
Study #:
3
Study Type:
Safety
Study Design:
Single-Blind/Placebo/Parallel Group/Dose Response
No Patients:
90
No Centers:
36
No Countries:
7
BPCA(B), PREA(P):
B
Asian:
1
Black:
27
Other:
25
White:
37
Native Hawaiian or Pacific Islander:
0
American Indian/Alaska Native:
0
Hispanic/Latino:
0
Non-Hispanic/Non Latino:
0
-
-